Treatment of liposarcomas using a combination of thiazolidinediones and retinoid X receptor selective agonists
AssigneeThe Salk Institute for Biological Studies
InventorsRonald M. Evans, Peter Tontonoz, Bruce M. Spiegelman, Barry M. Forman
Life of this patent
Estimating the term…